Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Mattei

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Jornal De Pediatria|February 24, 2004
[Clinical features in osteosarcoma and prognostic implications]Angela Rech, Cláudio G Castro, Jane Mattei, et al.
Archives of Pathology & Laboratory Medicine|January 1, 2014
Gastrin-releasing peptide receptor expression in lung cancerJane Mattei, Rosane D Achcar, Carlos H Cano, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Frontiers in Oncology|November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanomaJoel Ho, Jane Mattei, Michael Tetzlaff, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Jornal De Pediatria|February 24, 2004
[Clinical features in osteosarcoma and prognostic implications]Angela Rech, Cláudio G Castro, Jane Mattei, et al.
Archives of Pathology & Laboratory Medicine|January 1, 2014
Gastrin-releasing peptide receptor expression in lung cancerJane Mattei, Rosane D Achcar, Carlos H Cano, et al.
Melanoma Research|December 3, 2025
Adjuvant therapy in mucosal melanoma: a single-center experience and review of the literatureJane Mattei, Lin Ruitao, Michael A Davies, et al.
Frontiers in Oncology|November 3, 2022
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanomaJoel Ho, Jane Mattei, Michael Tetzlaff, et al.
Pageof 3